rhuMAb 2C4

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for rhuMAb 2C4, covering 2015-06-10 to 2015-11-25. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors [Phase 1]